Maculopapular rash associated with risperidone in a child

dc.contributor.authorGuler, Hasan Ali
dc.contributor.authorTurkoglu, Serhat
dc.contributor.authorGuler, Dilara
dc.date.accessioned2020-03-26T20:15:07Z
dc.date.available2020-03-26T20:15:07Z
dc.date.issued2019
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractRisperidone is an atypical antipsychotic that antagonizes 5HT2A and D2 receptors. Risperidone is used for many indications in children and adolescents. These indications include bipolar mania, schizophrenia, disruptive behaviour disorders, and aggression associated with autism spectrum disorder/mental retardation. Although it is usually well tolerated, weight gain, somnolence, rhinitis, headache, and rising appetite are among the most noticed side effects. Here we present a 5-year-old boy who developed diffuse nonpruritic maculopapular skin rash with a stable dosage of risperidone in the eighth month of treatment.en_US
dc.identifier.doi10.1080/24750573.2018.1468639en_US
dc.identifier.endpage528en_US
dc.identifier.issn2475-0573en_US
dc.identifier.issn2475-0581en_US
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage527en_US
dc.identifier.urihttps://dx.doi.org/10.1080/24750573.2018.1468639
dc.identifier.urihttps://hdl.handle.net/20.500.12395/37987
dc.identifier.volume29en_US
dc.identifier.wosWOS:000510621700008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherTAYLOR & FRANCIS LTDen_US
dc.relation.ispartofPSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectRisperidoneen_US
dc.subjectskin rashen_US
dc.subjectchilden_US
dc.subjectbehavioural problemen_US
dc.subjectantipsychoticen_US
dc.subjectside effectsen_US
dc.titleMaculopapular rash associated with risperidone in a childen_US
dc.typeEditorialen_US

Dosyalar